Literature DB >> 11843094

Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives.

Osamu Hayaishi1, Yoshihiro Urade.   

Abstract

Prostaglandin (PG) D2 is one of the most active endogenous sleep-promoting substances, which induces physiological sleep in rodents, primates, and most probably in humans as well. In this update article, we review recent experimental results concerning the molecular mechanisms underlying sleep-wake regulation by PGD2, the link between the humoral regulation by the PGD2 system, and the neural network involved in the promotion of non-rapid eye movement (NREM) sleep and the abnormality of NREM sleep regulation found in gene-manipulated mice for PGD synthase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843094     DOI: 10.1177/107385840200800105

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  22 in total

1.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

Review 2.  Chronic rhinosinusitis and sleep: a contemporary review.

Authors:  Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2013-08-26       Impact factor: 3.858

3.  Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study.

Authors:  Jeremiah A Alt; Nathan B Sautter; Jess C Mace; Kara Y Detwiller; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-10-22       Impact factor: 3.325

4.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

5.  Estradiol regulation of lipocalin-type prostaglandin D synthase promoter activity: evidence for direct and indirect mechanisms.

Authors:  Nino Devidze; Ko Fujimori; Yoshihiro Urade; Donald W Pfaff; Jessica A Mong
Journal:  Neurosci Lett       Date:  2010-03-01       Impact factor: 3.046

6.  Adenosine A2A receptor deficiency attenuates the somnogenic effect of prostaglandin D2 in mice.

Authors:  Bin-Jia Zhang; Zhi-Li Huang; Jiang-Fan Chen; Yoshihiro Urade; Wei-Min Qu
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

7.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

8.  Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers.

Authors:  Monika Haack; Elsa Sanchez; Janet M Mullington
Journal:  Sleep       Date:  2007-09       Impact factor: 5.849

9.  Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep.

Authors:  Akira Terao; Zhi-Li Huang; Jonathan P Wisor; Takatoshi Mochizuki; Dmitry Gerashchenko; Yoshihiro Urade; T S Kilduff
Journal:  J Neurochem       Date:  2008-03-07       Impact factor: 5.372

Review 10.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.